6 Stocks Cathie Wood Is Buying and Selling (And Tesla Is One of Them)

Cathie Wood, the CEO of ARK Invest, has become a household name in the investing world due to her bold bets on disruptive technologies.

Known for her forward-thinking strategies and deep dives into innovative industries, Wood's investment decisions often spark interest among retail and institutional investors alike. 

Her recent moves reflect her ongoing focus on high-growth sectors while showcasing her willingness to pivot when the market landscape changes.

We examine three stocks Wood is currently buying and three she recently sold. Understanding these choices can offer valuable insights whether you want to start investing or refine your portfolio.

Wood's latest purchases highlight her belief in the long-term potential of cutting-edge industries, from advertising technology to genomics. Here are three stocks that Wood is adding to her portfolio.

The Trade Desk, a leader in programmatic advertising, has recently captured Wood's attention. The company's platform empowers advertisers to make data-driven decisions, providing a competitive edge in digital marketing.

Despite macroeconomic challenges, The Trade Desk reported strong revenue growth and continues innovating in areas like connected TV. Wood's decision to invest shows her confidence in the future of digital advertising as traditional methods decline.

Pacific Biosciences (or PacBio for short), a company specializing in advanced DNA sequencing technologies, is another of Wood's recent buys.

This firm is at the forefront of genomics and is the leader in long-read gene sequencing, offering tools that allow scientists to study genetic variations with unparalleled accuracy.

The demand for genomic solutions is rising in healthcare and research, and PacBio's innovative approach positions it as a key player in the industry. Wood's investment reflects her long-term optimism about the role of genomics in transforming medicine and personalized healthcare.

Smart Drivers, Smarter Savings

Compare car insurance rates in Ohio

See if you qualify for a lower rate in less than 2 minutes

Check Rates

By clicking the button above, I understand and agree that this site uses site visit recording technology (provided by Trusted Form, Jornaya, and Microsoft Clarity) Privacy Policy

Guardant Health focuses on liquid biopsy technology, an innovative approach to cancer diagnostics that uses blood samples instead of invasive procedures. 

The company's mission to detect cancer early and guide treatment decisions aligns with ARK Invest's emphasis on disruptive healthcare technologies.

With increasing product adoption and a robust pipeline, Guardant Health has strong growth potential. Wood's purchase signals her belief in the broader trend of precision medicine.

Wood's recent sales reflect her readiness to adjust her portfolio, even when it means parting with high-profile names. Here are three stocks she's recently decided to part with.

Tesla, perhaps the most notorious automaker in the EV space, has been a cornerstone of ARK Invest's portfolio for years. However, Wood recently trimmed her holdings in the EV giant.

This move comes amid concerns about a potential stock sell-off despite her continued belief in the company.

Tesla's stock has seen significant volatility, and while Wood remains bullish on its long-term potential, this sale suggests a tactical reallocation of funds toward other growth opportunities.

Unity Software, a real-time 3D content creation platform, has been another stock Wood reduced her exposure. Despite its prominence in gaming and other interactive media, the company has faced challenges, including posting losses, making leadership changes, and cutting jobs.

Wood's decision to sell could reflect concerns about Unity's ability to navigate these headwinds, particularly as competition in the metaverse and immersive content space intensifies.

SoFi Technologies, a fintech company specializing in digital banking and personal finance, is the latest high-growth stock Wood has sold. Despite strong user growth and improving financials, Wood sold a significant portion of her holdings even though the stock price was up.

This sale aligns with Ark Invest's strategy of sometimes trimming positions to reallocate capital to other opportunities. Wood's move could suggest that she's prioritizing balance in her portfolio amid SoFi's recent surge.

From betting on innovative companies like Guardant Health to scaling back on big names like Tesla, Wood's decisions demonstrate her commitment to staying ahead of market trends while adapting to shifting dynamics.

If you're inspired by her strategies, consider how her picks align with your financial goals. Are you ready to make money moves and build wealth by focusing on disruptive innovation?

The key is finding a balance that works for your risk tolerance and long-term objectives.